• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Considerations on the use of Neisseria meningitidis class 5 proteins as meningococcal BC vaccine components.

作者信息

Sacchi C T, Gorla M C, de Lemos A P, Brandileone M C

机构信息

Bacteriology Division, Adolfo Lutz Institute, São Paulo, Brazil.

出版信息

Vaccine. 1995 Jan;13(1):112-8. doi: 10.1016/0264-410x(95)80021-5.

DOI:10.1016/0264-410x(95)80021-5
PMID:7762267
Abstract

This investigation was carried out to evaluate the importance of individual meningococcal surface class 5 protein with respect to antibody induction and its functional activity. Two groups of mice were immunized with two vaccine preparations differing in the presence or absence of class 5 protein. The ELISA results show that both vaccines were immunogenic and elicited mainly IgG antibodies against the major classes of meningococcal surface proteins, and the absence of class 5 protein in the vaccine produced a significant change in the overall units ml-1 of antibodies against the homologous strain. The infant rat model and the bactericidal assay were used to evaluate the functional antibody activity. Our results showed that (1) even using two different challenge doses (10(6) and 10(7) bacteria/animal), mortality could not be detected when followed up at 48 h; (2) there was protection as determined by the infant rat model and bactericidal activity using sera from both vaccinated groups; (3) there were no differences in the bactericidal titres between these groups; (4) in the infant rat model there were no differences in the index of bacteraemia among the infected animals (counts ml-1 of blood); and (5) there were differences in the incidence of bacteraemia. This is the first evidence that some immunological differences in the vaccine response could be attributed to the absence of class 5 protein by using infant rat model but not by using the bactericidal assay.

摘要

相似文献

1
Considerations on the use of Neisseria meningitidis class 5 proteins as meningococcal BC vaccine components.
Vaccine. 1995 Jan;13(1):112-8. doi: 10.1016/0264-410x(95)80021-5.
2
Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.抗B群脑膜炎奈瑟菌15:P1.16血清型1类和3类外膜蛋白单克隆抗体在幼鼠感染模型中的保护效力:疫苗研发的新前景
Microb Pathog. 1987 Oct;3(4):261-7. doi: 10.1016/0882-4010(87)90059-3.
3
Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay.通过幼鼠被动保护和体外杀菌试验对B群脑膜炎球菌疫苗潜在成分进行比较评估。
Vaccine. 1989 Aug;7(4):325-8. doi: 10.1016/0264-410x(89)90194-1.
4
Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.由一种过表达基因组衍生的奈瑟氏菌抗原1870的脑膜炎球菌外膜囊泡疫苗引发的保护性抗体反应。
J Infect Dis. 2005 Aug 15;192(4):580-90. doi: 10.1086/432102. Epub 2005 Jul 15.
5
A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice.一种天然外膜囊泡疫苗可保护人CEACAM1转基因小鼠免受脑膜炎球菌定植。
Vaccine. 2015 Mar 10;33(11):1317-1323. doi: 10.1016/j.vaccine.2015.01.057. Epub 2015 Feb 4.
6
Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae.用重组截短脑膜炎奈瑟菌-巨噬细胞感染增强蛋白(rT-Nm-MIP)免疫可诱导产生对淋病奈瑟菌具有交叉反应性和杀菌活性的鼠抗体。
Vaccine. 2018 Jun 22;36(27):3926-3936. doi: 10.1016/j.vaccine.2018.05.069. Epub 2018 May 24.
7
Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity.针对基因组衍生的奈瑟氏菌抗原2132(一种脑膜炎奈瑟氏菌候选疫苗)的抗体,在缺乏补体介导的杀菌活性的情况下可提供针对菌血症的保护。
J Infect Dis. 2003 Dec 1;188(11):1730-40. doi: 10.1086/379375. Epub 2003 Nov 19.
8
Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.抗B群脑膜炎奈瑟菌表面蛋白A单克隆抗体对B群脑膜炎奈瑟菌菌株的功能活性
Infect Immun. 2001 Jun;69(6):3762-71. doi: 10.1128/IAI.69.6.3762-3771.2001.
9
Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine.针对基因组衍生的奈瑟氏菌抗原1870的单克隆抗体的保护活性,一种脑膜炎奈瑟氏菌候选疫苗
J Immunol. 2004 May 1;172(9):5606-15. doi: 10.4049/jimmunol.172.9.5606.
10
Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial.A/C 群脑膜炎奈瑟菌寡糖-蛋白结合疫苗在幼儿中的安全性和免疫原性。一项随机对照试验。
JAMA. 1996 May 15;275(19):1499-503.

引用本文的文献

1
Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.孔蛋白 B2 抑制非人婴儿补体替代途径有助于脑膜炎奈瑟菌在婴儿鼠模型中的毒力。
Infect Immun. 2014 Jun;82(6):2574-84. doi: 10.1128/IAI.01517-14. Epub 2014 Mar 31.
2
Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidis.针对脑膜炎奈瑟菌重组OpaJ蛋白的抗体的功能活性
Infect Immun. 2003 May;71(5):2331-40. doi: 10.1128/IAI.71.5.2331-2340.2003.
3
Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes.
天然外膜蛋白Oms66(p66)对宿主适应性伯氏疏螺旋体的保护作用:杀菌表位的构象性质
Infect Immun. 2000 May;68(5):2647-54. doi: 10.1128/IAI.68.5.2647-2654.2000.
4
Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.巴西儿童接种外膜疫苗后对B群脑膜炎球菌菌株杀菌抗体反应的特异性
Infect Immun. 1998 Oct;66(10):4755-61. doi: 10.1128/IAI.66.10.4755-4761.1998.
5
Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.三剂挪威B群脑膜炎球菌疫苗接种后人体对脑膜炎球菌外膜抗原的抗体反应。
Infect Immun. 1995 Dec;63(12):4642-52. doi: 10.1128/iai.63.12.4642-4652.1995.